Home/Pipeline/Taltz (ixekizumab)

Taltz (ixekizumab)

Psoriasis

ApprovedCommercial

Key Facts

Indication

Psoriasis

Phase

Approved

Status

Commercial

Company

Eli Lilly

About Eli Lilly

Eli Lilly is one of the world's largest pharmaceutical companies with over 145 years of experience in developing life-changing medicines. The company has achieved significant recent success with GLP-1 receptor agonists for diabetes and weight management, generating substantial revenue growth. Lilly continues to invest heavily in R&D across key therapeutic areas including diabetes, oncology, autoimmune diseases, and neurodegeneration, with a robust pipeline of innovative treatments in development.

View full company profile

Therapeutic Areas

Diabetes Oncology Immunology Neuroscience Obesity Cardiovascular

Other Psoriasis Drugs

Drug	Company	Phase	Status
Ilumya (tildrakizumab)	Sun Pharmaceutical	Approved	Commercial
SCD-044	Sun Pharmaceutical	Phase 2	Active
Itolizumab	Biocon	Approved	Commercial
SCD-105	SPARC	Phase 2	Completed
IMP731	Immutep	Phase 1/Ib	Completed
CYPS317	FibroBiologics	Discovery	Active